Globe Editorial
A new study in JAMA raises new cautions about prescribing anti-psychotic drugs for off-label uses (such as dementia in the elderly or attention deficit disorder among kids). (Full article: 432 words)
This article is available in our archives:
Globe Subscribers
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly





